AmerisourceBergen Announces Sale of AndersonBrecon
VALLEY FORGE, Pa.-- AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to sell its contract packaging business, AndersonBrecon, to an entity formed...
Frazier Healthcare Acquires AndersonBrecon from AmerisourceBergen
Frazier Healthcare is pleased to announce that it has signed a definitive agreement to acquire AndersonBrecon, the contract pharmaceutical packaging business and wholly owned subsidiary of...
LabCorp Clinical Trials Selected as a Preferred Provider for Global Central Laboratory Services by Bristol-Myers Squibb
BURLINGTON, N.C.--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that LabCorp Clinical Trials has been selected as a preferred provider for full-service...
SK Biopharmaceuticals Announces a Strategic Alliance for Innovative Drug Development with Chinese Biopharmaceutical Companies
SEOUL, South Korea--The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and...
PPD Expands cGMP Cell-based Assay Laboratory
WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) is expanding its cGMP cell-based assay laboratory in Middleton, Wis., to meet the growing needs of clients seeking to validate...
Biotrial, a Successful Leading CRO, Continues to Expand its Activities, Creating a Unique Neuroscience Pool of Talent and Capabilities: Biotrial Neuroscience
Biotrial Neuroscience increases its capabilities in clinical CNS assessments by strengthening its expertise and acquiring new technology In order to meet the biopharmaceutical market's growing need...
ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
FORT WASHINGTON, Pa. and TOKYO, March 27, 2013 -- ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research organization (CRO), and Asklep Inc. ("Asklep"),...
bioRASI Completes Acquisition of Ukrainian CRO
Aventura, FL -- March 28, 2013 -- bioRASI, a full service, global Contract Research Organization (CRO), announced today that it has acquired Sponsors Clinical Research Group, LLC (SCRG), a Ukrainian...
PPD's Bioanalytical Labs Certified as a Center of Bioavailability/Bioequivalence of Medicines by Brazil's National Health Surveillance Agency
WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) today announced its bioanalytical operation has been certified by Brazil's Agencia Nacional de Vigilancia Sanitaria (ANVISA),...
Veristat's collaboration with Aegerion contributes to FDA approval of Juxtapid™
HOLLISTON, Mass.--Veristat, a leading Clinical Research Organization (CRO), applauds Aegerion Pharmaceuticals on their recent FDA approval of Juxtapid for the treatment of patients with homozygous...
Sanofi and Transgene Announce Innovative Long-Term Collaboration for the Production of Immunotherapy Treatments
Sanofi (EURONEXT: SAN and NYSE: SNY) and Transgene SA (Paris:TNG) (NYSE-Euronext: TNG) announced today a collaboration agreement for the creation of a new state-of-the-art industrial platform...
Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial
SYDNEY and DURHAM, N.C., March 21, 2013 -- RNAi-based therapeutics company Benitec Biopharma Limited (ASX Code: BLT) today announced the selection of the Duke Clinical Research Unit, the early phase...
DKSH extends partnership with Bayer HealthCare in Cambodia
Phnom Penh, Cambodia – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, signed a five year agreement with Bayer HealthCare, a...
Dr. Reddy's and Nordion Inc. (formerly MDS Inc.) Settle Claims
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) announced today that it had settled its claims against Nordion Inc. (formerly MDS Inc.), headquartered in Ottawa, Canada, in a...
Nordion and Dr. Reddy's Laboratories Settle Claims
Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, has settled claims filed against Nordion by Dr. Reddy's Laboratories Ltd. and...
ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement
SHANGHAI, March 20, 2013 -- ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today...
INC Research Appoints James Taylor Vice President, Clinical Development
Raleigh, N.C. - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced James Taylor has...
DATATRAK International, Inc. Reports Fourth Quarter and Full Year Results for 2012
CLEVELAND, March 13, 2013 -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical™ technologies and delivering related services for the clinical...
Calvert Labs And Particle Sciences Form Strategic Partnership To Streamline Early-Stage Drug Development
Scott Township, PA – Calvert Laboratories and Particle Sciences, two leading companies in their respective fields of preclinical toxicology and drug product formulation, announced today that...
Sunshine Biopharma Commences Negotiations With Contract Manufacturing Organizations for Production of Its Multidrug-Resistant Breast Cancer Drug, Adva-27a
MONTREAL - Sunshine Biopharma Inc. ( OTCQB : SBFM ), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, is...
